Intelomed

Intelomed

Early Stage

Real-time Remote Health Metrics

Real-time Remote Health Metrics

Overview

Raised to Date: Raised: $98,095

Total Commitments ($USD)

Platform

StartEngine

Start Date

10/10/2022

Close Date

01/10/2023

Min. Goal
$10,000
Max. Goal
$1,069,999
Min. Investment

$101

Security Type

Equity - Preferred

Series

Seed

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$1.20

Pre-Money Valuation

$28,087,014

Rolling Commitments ($USD)

Status
Not Funded
Reporting Date

01/30/2023

Days Remaining
Not Funded
% of Min. Goal
Not Funded
% of Max. Goal
Not Funded
Likelihood of Max
Not Funded
Avg. Daily Raise

$1,078

# of Investors

35

Momentum
Not Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded

2005

Industry

Healthcare & Pharmaceuticals

Tech Sector

HealthTech

Distribution Model

B2B/B2C

Margin

Medium

Capital Intensity

Low

Location

Cranberry Township, Pennsylvania

Business Type

Growth

Intelomed, with a valuation of $28.1 million, is raising funds on StartEngine. The company is developing a contactless patient-monitoring device to improve telehealth treatment outcomes. The technology of Intelomed uses the camera of a smartphone combined with its Mobile Cardiovascular Insight to measure the microchanges in a patient’s facial color to provide valuable diagnostics to clinicians. Intelomed is led by an experienced team and aims to improve treatment capabilities drastically. William P. Malloy founded Intelomed in February 2005. The current crowdfunding campaign has a minimum target of $9,999.60 and a maximum target of $1.07 million. The campaign proceeds will be used to pursue FDA clearance.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$33,203

$14,150

COGS

$3,752

$70

Tax

$0

$0

 

 

Net Income

$-1,266,445

$-1,265,112

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$267,374

$738,197

Accounts Receivable

$14,760

$3,440

Total Assets

$513,556

$991,820

Short-Term Debt

$108,150

$102,511

Long-Term Debt

$5,334,624

$4,552,082

Total Liabilities

$5,442,774

$4,654,593

Financials as of: 10/10/2022
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
Intelomed on StartEngine 2022
Platform: StartEngine
Security Type: Equity - Preferred
Valuation: $28,087,014
Price per Share: $1.20

Follow company

Follow Intelomed on StartEngine 2022

Buy Intelomed's Deal Report

Warning: according to the close date for this deal, Intelomed may no longer be accepting investments.

Intelomed Deal Report

Get KingsCrowd’s comprehensive report on Intelomed including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Intelomed is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Intelomed deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge